Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer

BACKGROUND: Anti-epidermal growth factor receptor therapy is associated with skin adverse events not previously reported with conventional chemotherapy. Prophylactic actions are recommended, but routine clinical management of these toxicities and their impact on quality of life remain unknown. AIM:...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouché, Olivier, Ben Abdelghani, Meher, Labourey, Jean-Luc, Triby, Simon, Bensadoun, René-Jean, Jouary, Thomas, Des Guetz, Gaétan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689814/
https://www.ncbi.nlm.nih.gov/pubmed/31413534
http://dx.doi.org/10.3748/wjg.v25.i29.4007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689814/
https://www.ncbi.nlm.nih.gov/pubmed/31413534
http://dx.doi.org/10.3748/wjg.v25.i29.4007

Ejemplares similares